Jagdish Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-07-2024
- Paid Up Capital ₹ 0.50 M
as on 10-07-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.00 M
as on 10-07-2024
- Revenue 21.89%
(FY 2022)
- Profit -20.00%
(FY 2022)
- Ebitda -14.68%
(FY 2022)
- Net Worth 25.44%
(FY 2022)
- Total Assets -10.30%
(FY 2022)
About Jagdish Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹6.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sunita Tambi, Purushotam Dusad, and Bhag Khandelwal serve as directors at the Company.
- CIN/LLPIN
U85100RJ2014PTC046595
- Company No.
046595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jagdish Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunita Tambi  | Director | 21-Nov-2014 | Current |
| Purushotam Dusad | Director | 21-Nov-2014 | Current |
| Bhag Khandelwal | Director | 21-Nov-2014 | Current |
Financial Performance of Jagdish Healthcare.
Jagdish Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.89% increase. The company also saw a substantial fall in profitability, with a 20% decrease in profit. The company's net worth Soared by an impressive increase of 25.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagdish Healthcare?
In 2020, Jagdish Healthcare had a promoter holding of 77.00% and a public holding of 23.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Disha Hospitals Private LimitedActive 29 years 29 daysSunita Tambi and Bhag Khandelwal are mutual person
- Erikson Pharmaceuticals Private LimitedActive 28 years 10 months
Purushotam Dusad is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 02 Sep 2015 | ₹6.00 M | Satisfied |
How Many Employees Work at Jagdish Healthcare?
Unlock and access historical data on people associated with Jagdish Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagdish Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagdish Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
